Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A
Clinical trial NCT05042440 · COMPLETED
Trial details
- NCT number
- NCT05042440
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2021-11-24
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.